T. Rowe Price Associates »

Heron Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 26k 1.74
2023-09-30 $22k 21k 1.06
2023-06-30 $66k 57k 1.17
2023-03-31 $83k 55k 1.52
2022-12-31 $121k 48k 2.51
2022-03-31 $190k 33k 5.72
2021-12-31 $274k 30k 9.13
2021-09-30 $571k 53k 10.69
2021-06-30 $785k 51k 15.52
2021-03-31 $931k 57k 16.21
2020-12-31 $1.5M 71k 21.16
2020-09-30 $1.1M 72k 14.82
2020-06-30 $928k 63k 14.70
2020-03-31 $726k 62k 11.74
2019-12-31 $1.0M 43k 23.50
2019-09-30 $1.1M 60k 18.49
2019-06-30 $882k 48k 18.59
2019-03-31 $1.2M 47k 24.44
2018-12-31 $1.2M 47k 25.95
2018-09-30 $1.1M 34k 31.66
2018-06-30 $338k 8.7k 38.84
2017-06-30 $144k 10k 13.81